Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08BST
|
||||
Former ID |
DNC013698
|
||||
Drug Name |
N-isobutylnoroxymorphone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529662] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H25NO4
|
||||
Canonical SMILES |
CC(C)CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O
|
||||
InChI |
1S/C20H25NO4/c1-11(2)10-21-8-7-19-16-12-3-4-13(22)17(16)25-18(19)14(23)5-6-20(19,24)15(21)9-12/h3-4,11,15,18,22,24H,5-10H2,1-2H3/t15-,18+,19+,20-/m1/s1
|
||||
InChIKey |
OEQLILQNMUXCHV-XFWGSAIBSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [529662] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [529662] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.